Viz.ai, a San Francisco-based disease detection and care coordination platform, raised $100 million in Series D funding led by Tiger Global and Insight Partners and was joined by investors including Scale Ventures, Kleiner Perkins, Threshold, GV, Sozo Ventures, CRV, and Susa, per Fortune’s Term Sheet.
Related Posts
MB2 Dental Secures $150M Debt Facility and Raises $20M from Doctor Partners
Since the inception of "sidecar" investments, MB2 doctor partners have invested over $75 million to help fuel the company's growth.
May 3, 2023
Smile Doctors Receives Strategic Investment from Thomas H. Lee Partners
Affiliated orthodontists will retain a significant ownership stake in the organization.
January 5, 2022
Healthcare-Focused Arisz Acquisition Prices $60M IPO
CEO and Chairwoman Echo Hindle-Yang in 2016 founded M.S.Q. Ventures, a New York-based advisory firm that focuses on integration for emerging life sciences companies.
November 18, 2021